Cargando…
Phospho-TCTP as a therapeutic target of dihydroartemisinin for aggressive breast cancer cells
Upregulation of Translationally Controlled Tumor Protein (TCTP) is associated with poorly differentiated aggressive tumors, including breast cancer, but the underlying mechanism(s) are still debated. Here, we show that in breast cancer cell lines TCTP is primarily localized in the nucleus, mostly in...
Autores principales: | Lucibello, Maria, Adanti, Sara, Antelmi, Ester, Dezi, Dario, Ciafrè, Stefania, Carcangiu, Maria Luisa, Zonfrillo, Manuela, Nicotera, Giuseppe, Sica, Lorenzo, De Braud, Filippo, Pierimarchi, Pasquale |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4467148/ https://www.ncbi.nlm.nih.gov/pubmed/25779659 |
Ejemplares similares
-
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2017) -
DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines
por: D’Amico, Silvia, et al.
Publicado: (2020) -
Correction to: Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer
por: Zhang, Fei, et al.
Publicado: (2019) -
Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy
por: Santamaria, Gianluca, et al.
Publicado: (2023) -
WNT-pathway components as predictive markers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer
por: Serafino, Annalucia, et al.
Publicado: (2014)